Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    November 2022
  1. SIEIRA J, Stroker E, Bala G, Overeinder I, et al
    Brugada Syndrome During Infancy and Childhood: 30 Years' Experience.
    J Am Coll Cardiol. 2022;80:1961-1962.
    PubMed    


    October 2022
  2. WALDMANN V, Marquie C, Bouzeman A, Duthoit G, et al
    Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.
    J Am Coll Cardiol. 2022;80:1701-1703.
    PubMed    


  3. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    PubMed     Abstract available


  4. LA GERCHE A, Wasfy MM, Brosnan MJ, Claessen G, et al
    The Athlete's Heart-Challenges and Controversies: JACC Focus Seminar 4/4.
    J Am Coll Cardiol. 2022;80:1346-1362.
    PubMed     Abstract available


    September 2022
  5. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    PubMed    


  6. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    PubMed    


  7. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    PubMed     Abstract available


  8. KANTER RJ
    Care of the Infant With Supraventricular Tachycardia: Toward a Better Paradigm.
    J Am Coll Cardiol. 2022;80:1173-1176.
    PubMed    


  9. MOORE JA, Stephens SB, Kertesz NJ, Evans DL, et al
    Clinical Predictors of Recurrent Supraventricular Tachycardia in Infancy.
    J Am Coll Cardiol. 2022;80:1159-1172.
    PubMed     Abstract available


  10. TZOU WS
    Insights From the Dilated Cardiomyopathy Ventricular Tachycardia Ablation Study: Wisdom Through Humility.
    J Am Coll Cardiol. 2022;80:1057-1059.
    PubMed    


  11. ZEPPENFELD K, Wijnmaalen AP, Ebert M, Baldinger SH, et al
    Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;80:1045-1056.
    PubMed     Abstract available


  12. BENALI K, Martins RP, Guenancia C, Da Costa A, et al
    Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
    J Am Coll Cardiol. 2022;80:e77.
    PubMed    


  13. ARENAL A, Avila P
    Reply: Survive the Threat of Slow VT.
    J Am Coll Cardiol. 2022;80:e79-e80.
    PubMed    


  14. REIFFEL JA
    Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome.
    J Am Coll Cardiol. 2022;80:e75.
    PubMed    


    August 2022
  15. CORBALAN R, Acevedo M
    Glifozins and Atrial Fibrillation.
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
    PubMed    


  16. MOHAMMADI-SHEMIRANI P, Chong M, Pare G
    Reply: Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e51.
    PubMed    


  17. HEGELE RA
    Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e49-e50.
    PubMed    


  18. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
    Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
    J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
    PubMed     Abstract available


  19. SCHMIDT B, Chun KRJ
    Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis.
    J Am Coll Cardiol. 2022;80:484-485.
    PubMed    


  20. DUKKIPATI SR, Holmes DR Jr, Doshi SK, Kar S, et al
    Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2022;80:469-483.
    PubMed     Abstract available


    July 2022
  21. SVENNBERG E
    How to Treat Patients With First-Diagnosed Atrial Fibrillation: The Less Clear Pattern?
    J Am Coll Cardiol. 2022;80:296-298.
    PubMed    


  22. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
    Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
    J Am Coll Cardiol. 2022;80:283-295.
    PubMed     Abstract available


  23. DE BACKER J, Narula J
    Cardiolaminopathies: Weighing in on the Concept of Genotype-First Screening.
    J Am Coll Cardiol. 2022;80:60-62.
    PubMed    


  24. LAZARTE J, Jurgens SJ, Choi SH, Khurshid S, et al
    LMNA Variants and Risk of Adult-Onset Cardiac Disease.
    J Am Coll Cardiol. 2022;80:50-59.
    PubMed     Abstract available


  25. SOLOW EB, Bermas BL
    Hydroxychloroquine: Heart-Throb No More?
    J Am Coll Cardiol. 2022;80:47-49.
    PubMed    


    June 2022
  26. GAUDINO M, Di Franco A, Rong LQ, Cao D, et al
    Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2529-2539.
    PubMed     Abstract available


  27. CURTIS AB, Korada SKC
    Should Atrial Fibrillation Be Included in Preoperative Risk Assessment for Noncardiac Surgery?
    J Am Coll Cardiol. 2022;79:2486-2488.
    PubMed    


  28. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    PubMed     Abstract available


  29. AHMED A, Pothineni NVK, Charate R, Garg J, et al
    Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2450-2462.
    PubMed     Abstract available


  30. TAKAHASHI T, Samuels BA, Li W, Parikh MA, et al
    Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
    J Am Coll Cardiol. 2022;79:2367-2378.
    PubMed     Abstract available


  31. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    PubMed     Abstract available


    May 2022
  32. RAJPAL S, Kahwash R, Tong MS, Paschke K, et al
    Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
    J Am Coll Cardiol. 2022;79:2144-2152.
    PubMed     Abstract available


  33. CAMM AJ, Naccarelli GV, Mittal S, Crijns HJGM, et al
    The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1932-1948.
    PubMed     Abstract available


  34. FREEMAN JV, Higgins AY, Wang Y, Du C, et al
    Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:1785-1798.
    PubMed     Abstract available


  35. HOLMES DR JR
    Antithrombotic Therapy After Left Atrial Appendage Occlusion: Cornucopia and Gertrude Stein.
    J Am Coll Cardiol. 2022;79:1799-1801.
    PubMed    


    April 2022
  36. KIM DS, Khandelwal A
    Lipoprotein(a) and Incident Atrial Fibrillation: Leveraging Nature's Randomization to Identify Novel Causal Associations.
    J Am Coll Cardiol. 2022;79:1591-1593.
    PubMed    


  37. MOHAMMADI-SHEMIRANI P, Chong M, Narula S, Perrot N, et al
    Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
    J Am Coll Cardiol. 2022;79:1579-1590.
    PubMed     Abstract available


  38. AMUTHAN R, Curtis AB
    Sex-Specific Considerations in Drug and Device Therapy of Cardiac Arrhythmias: JACC Focus Seminar 6/7.
    J Am Coll Cardiol. 2022;79:1519-1529.
    PubMed     Abstract available


  39. SALEEM M, Costanzo MR
    Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
    J Am Coll Cardiol. 2022;79:1454-1457.
    PubMed    


  40. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed     Abstract available


  41. PICCINI JP, Harrington J
    Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?
    J Am Coll Cardiol. 2022;79:1382-1384.
    PubMed    


  42. SCHWEIZER J, Arnold M, Konig IR, Bicvic A, et al
    Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
    J Am Coll Cardiol. 2022;79:1369-1381.
    PubMed     Abstract available


    March 2022
  43. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
    Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1199-1211.
    PubMed     Abstract available


  44. FRIEDMAN DJ, Qin L, Parzynski C, Heist EK, et al
    Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
    J Am Coll Cardiol. 2022;79:1050-1059.
    PubMed     Abstract available


  45. MARWICK TH, Brugger N
    Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
    J Am Coll Cardiol. 2022;79:962-964.
    PubMed    


  46. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
    Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:951-961.
    PubMed     Abstract available


    February 2022
  47. ROMANOV A, Lomivorotov V, Chernyavskiy A, Murtazin V, et al
    Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes.
    J Am Coll Cardiol. 2022;79:754-756.
    PubMed    


  48. ZAFEIROPOULOS S, Doundoulakis I, Farmakis IT, Miyara S, et al
    Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:682-694.
    PubMed     Abstract available


  49. LEYVA F, Zegard A, Okafor O, Foley P, et al
    Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.
    J Am Coll Cardiol. 2022;79:665-678.
    PubMed     Abstract available


  50. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    PubMed    


  51. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    PubMed     Abstract available


    January 2022
  52. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    PubMed     Abstract available


  53. MERCHANT FM
    Does Percutaneous Left Atrial Appendage Closure Stand the Test of Time?
    J Am Coll Cardiol. 2022;79:15-17.
    PubMed    


    December 2021
  54. NORBY FL, Benjamin EJ, Alonso A, Chugh SS, et al
    Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.
    J Am Coll Cardiol. 2021;78:2563-2572.
    PubMed     Abstract available


  55. SALMASI S, De Vera MA, Safari A, Lynd LD, et al
    Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:2395-2404.
    PubMed     Abstract available


  56. SAHA SA
    Premature Ventricular Complexes During Exercise in Asymptomatic Adults: Do They Deserve a Closer Look?
    J Am Coll Cardiol. 2021;78:2278-2280.
    PubMed    


  57. REFAAT MM, Gharios C, Moorthy MV, Abdulhai F, et al
    Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.
    J Am Coll Cardiol. 2021;78:2267-2277.
    PubMed     Abstract available


    November 2021
  58. MARQUEZ MF
    The Quest for the Evidence of Effectiveness of Implantable Cardioverter-Defibrillators in Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2089-2091.
    PubMed    


  59. WANG M, Peterson DR, Rosero S, McNitt S, et al
    Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2076-2088.
    PubMed     Abstract available


  60. TERTULIEN T, Magnani JW, Essien UR
    Racial and Ethnic Representation in Atrial Fibrillation Trials: CABANA and Beyond.
    J Am Coll Cardiol. 2021;78:e163-e164.
    PubMed    


  61. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
    Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e159.
    PubMed    


  62. WANG X, Wang P, Pei H
    Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e157.
    PubMed    


    October 2021
  63. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.
    J Am Coll Cardiol. 2021 Oct 27. pii: S0735-1097(21)07895.
    PubMed     Abstract available


  64. ERNAULT AC, Meijborg VMF, Coronel R
    Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1730-1745.
    PubMed     Abstract available


  65. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
    Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1682-1699.
    PubMed     Abstract available


  66. BEHR ER
    J-Wave Syndromes, SCN5A, and Cardiac Conduction Reserve: Two Sides of the Same Coin?
    J Am Coll Cardiol. 2021;78:1618-1620.
    PubMed    


  67. ZHANG ZH, Barajas-Martinez H, Xia H, Li B, et al
    Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    J Am Coll Cardiol. 2021;78:1603-1617.
    PubMed     Abstract available


  68. ASATRYAN B, Odening KE, Reichlin T
    Myocardial Histopathology Studies in Brugada Syndrome Decedents: Structural Features of a Presumed Electrical Disease.
    J Am Coll Cardiol. 2021;78:1522-1524.
    PubMed    


  69. MILES C, Asimaki A, Ster IC, Papadakis M, et al
    Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2021;78:1511-1521.
    PubMed     Abstract available


    September 2021
  70. LURIE A, Wang J, Healey JS, Wong JA, et al
    Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:e91-e92.
    PubMed    


  71. KADISH A, Jacobson J
    Sleep Patterns and Arrhythmias: Should This Keep Us Awake at Night?
    J Am Coll Cardiol. 2021;78:1208-1209.
    PubMed    


  72. LI X, Zhou T, Ma H, Huang T, et al
    Healthy Sleep Patterns and Risk of Incident Arrhythmias.
    J Am Coll Cardiol. 2021;78:1197-1207.
    PubMed     Abstract available


    August 2021
  73. ANDRADE JG, Wazni OM, Kuniss M, Hawkins NM, et al
    Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:914-930.
    PubMed     Abstract available


  74. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
    Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
    J Am Coll Cardiol. 2021;78:643-662.
    PubMed     Abstract available


  75. BERG DD, Giugliano RP, Ruff CT, Tang M, et al
    A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.
    J Am Coll Cardiol. 2021;78:634-636.
    PubMed    


    July 2021
  76. WAZNI O, Saliba W, Hussein AA
    Device-Related Thrombus After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:314-316.
    PubMed    


  77. SIMARD T, Jung RG, Lehenbauer K, Piayda K, et al
    Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:297-313.
    PubMed     Abstract available


  78. THOMAS KL, Al-Khalidi HR, Silverstein AP, Monahan KH, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:126-138.
    PubMed     Abstract available


  79. RUSSO AM
    Catheter Ablation Is Better Than Drugs for Treatment of AF in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:139-141.
    PubMed    


    June 2021
  80. GRANGER CB, Pokorney SD
    Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:3002-3004.
    PubMed    


  81. DI MARCO A, Brown PF, Bradley J, Nucifora G, et al
    Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;77:2890-2905.
    PubMed     Abstract available


  82. LURIE A, Wang J, Hinnegan KJ, McIntyre WF, et al
    Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:2875-2886.
    PubMed     Abstract available


  83. KIRCHHOF P, Sinning C
    Thrombus or No Thrombus: Is That the Embolic Question?
    J Am Coll Cardiol. 2021;77:2887-2889.
    PubMed    


  84. CHEN YC, Voskoboinik A, Gerche A, Marwick TH, et al
    Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2846-2864.
    PubMed     Abstract available


  85. TREVISAN F, Bertini M, Balla C, Pestelli G, et al
    Type 1 Brugada Pattern Is Associated With Echocardiography-Detected Delayed Right Ventricular Outflow Tract Contraction.
    J Am Coll Cardiol. 2021;77:2865-2867.
    PubMed    


  86. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    PubMed     Abstract available


    May 2021
  87. TOBERT KE, Bos JM, Garmany R, Ackerman MJ, et al
    Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death.
    J Am Coll Cardiol. 2021 May 26. pii: S0735-1097(21)04779.
    PubMed     Abstract available


  88. AKTAS MK, Younis A, Zareba W, Kutyifa V, et al
    Survival After Implantable Cardioverter-Defibrillator Shocks.
    J Am Coll Cardiol. 2021;77:2453-2462.
    PubMed     Abstract available


  89. DEO R, Pothineni NVK
    The "Shocking" Reality of ICD Therapies.
    J Am Coll Cardiol. 2021;77:2463-2465.
    PubMed    


  90. CHRISTENSEN AH, Nyholm BC, Vissing CR, Pietersen A, et al
    Natural History and Clinical Characteristics of the First 10 Danish Families With Familial ST-Depression Syndrome.
    J Am Coll Cardiol. 2021;77:2617-2619.
    PubMed    


  91. PRIORI SG, Mazzanti A, Santiago DJ, Kukavica D, et al
    Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2021;77:2592-2612.
    PubMed     Abstract available


  92. GIUDICESSI JR, Ackerman MJ, Fatkin D, Kovacic JC, et al
    Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2021;77:2573-2591.
    PubMed     Abstract available


  93. NACCARELLI GV, Filippone EJ, Foy A
    Do Mineralcorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04967.
    PubMed    


  94. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
    Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
    PubMed     Abstract available


    April 2021
  95. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


    March 2021
  96. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
    Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:1344-1356.
    PubMed     Abstract available


  97. CALO L, Della Bona R, Martino A, Crescenzi C, et al
    Left Posterior Fascicular Block and Increased Risk of Sudden Cardiac Death in Young People.
    J Am Coll Cardiol. 2021;77:1143-1145.
    PubMed    


    February 2021
  98. LYON AR, Citro R, Schneider B, Morel O, et al
    Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:902-921.
    PubMed     Abstract available


  99. COHEN MI, Khairy P, Zeppenfeld K, Van Hare GF, et al
    Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:761-771.
    PubMed     Abstract available


    January 2021
  100. ARAI AE, Bradley AJ, Sirajuddin A
    Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
    J Am Coll Cardiol. 2021;77:42-44.
    PubMed    


  101. ZEGARD A, Okafor O, de Bono J, Kalla M, et al
    Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:29-41.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: